The forecast predicts a gradual increase in anemia prevalence among pregnant women in the US, with rates rising steadily from 12.0% in 2024 to 12.4% in 2028. This follows the actual rate of 11.9% recorded in 2023. On a year-on-year basis, there is a consistent increase of approximately 0.1 percentage points annually. Over the five-year period, the compound annual growth rate (CAGR) is projected to stabilize around 0.83%, indicating a slow but steady upward trend.
Future trends to watch include changes in dietary patterns, healthcare access, and public health initiatives, which may either mitigate or exacerbate anemia prevalence. Monitoring these factors will be crucial for stakeholders aiming to address this public health concern effectively.
